Extensively Drug‐Resistant Tuberculosis: 2 Years of Surveillance in Iran
Open Access
- 1 October 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (7) , 841-847
- https://doi.org/10.1086/507542
Abstract
Background. Extensively drug-resistant (XDR) tuberculosis (TB) is a cause of concern, because it renders patients untreatable with available drugs. IKeywords
This publication has 17 references indexed in Scilit:
- Treatment of multiple drug-resistant tuberculosis (MDR-TB) in IranInternational Journal of Infectious Diseases, 2005
- Tuberculosis due to Resistant Haarlem Strain, TunisiaEmerging Infectious Diseases, 2005
- Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyThe Lancet, 2005
- Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?Journal of Antimicrobial Chemotherapy, 2004
- Multidrug-resistant Tuberculosis in Central AsiaEmerging Infectious Diseases, 2004
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- Multidrug-Resistant Tuberculosis in Prison Inmates, AzerbaijanEmerging Infectious Diseases, 2001
- [15] DNA Fingerprinting of mycobacterium tuberculosisPublished by Elsevier ,1994